Mp72-03 sorafenib-triggered stress granules promote resistance in renal cancer cells by recruiting anti-apoptotic cyclooxygenase 2

Wei Chen,Xiaozhi Zhao,Wenmin Cao,Wenli Diao,Hongqian Guo

DOI: https://doi.org/10.1016/j.juro.2018.02.2287

IF: 7.6

2018-01-01

The Journal of Urology

Abstract:You have accessJournal of UrologyKidney Cancer: Basic Research & Pathophysiology II1 Apr 2018MP72-03 SORAFENIB-TRIGGERED STRESS GRANULES PROMOTE RESISTANCE IN RENAL CANCER CELLS BY RECRUITING ANTI-APOPTOTIC CYCLOOXYGENASE 2 Wei Chen, Xiaozhi Zhao, Wenmin Cao, Wenli Diao, and Hongqian Guo Wei ChenWei Chen More articles by this author , Xiaozhi ZhaoXiaozhi Zhao More articles by this author , Wenmin CaoWenmin Cao More articles by this author , Wenli DiaoWenli Diao More articles by this author , and Hongqian GuoHongqian Guo More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.2287AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES A significant proportion of RCC patients are inherently refractory to sorafenib, and most of the remaining patients develop resistance. The stress granules (SGs) induced by sorafenib contributing to renal cancer cells resistance is unknown. METHODS In ACHN and 786O cells, SGs were shown by immunofluorescence using canonical SGs markers HuR, TIA-1 and G3BP1. The activation of GCN2 and the phosphorylation of its downstream eIF2α were detected by western blotting. Cells apoptosis percentages were measured by AnnexinV-PI staining. Cox2 mRNA level was evaluated by real-time quantitative polymerase chain reaction (RT-qPCR). RNA-FISH was performed using specific Cox2 mRNA probes. RESULTS We found that sorafenib can trigger the formation of many small cytoplasmic foci in renal cancer cells. These particles-like foci were characterized as stress granules (SGs), because they were nicely co-localized with SG markers HuR, TIA-1 and G3BP1 (Fig.1A, 1B). These SGs have a protective role. The SGs triggered by sorafenib were found to be dependent on GCN2-eIF2α signaling. Sorafenib increased the phosphorylation of General control nonderepressible kinase 2 (GCN2) and its downstream eIF2α without influencing the total protein. Silencing of GCN2 expression also promoted sorafenib-induced cell apoptosis and reduced the formation of SGs (Fig.1C). We found anti-apoptotic gene cyclooxygenase 2 (cox2) was recruited into SGs. And the expression of cox2 was higher in sorafenib-resistant cells. RNA-based fluorescence in-situ hybridization (RNA-FISH) experiment was performed to observe the cellular distribution of cox2 mRNA. In sorafenib-treated cells, many particle-like distribution of cox2 mRNAs were found to be co-localized with SGs (Fig.2). To override sorafenib resistance, we inactivated cox2 using celecoxib, a clinical analgesic specific cox2 inhibitor. A combination treatment with low dosage of celecoxib and sorafenib induces ACHN cells death more efficient than sorafenib alone (Fig.3). CONCLUSIONS The SGs triggered by sorafenib were dependent on GCN2-eIF2α signaling. Our findings suggest that a combination therapy of cox2 inhibitor celecoxib may represent a novel therapeutic approach for resistant RCC treatment. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e952-e953 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Wei Chen More articles by this author Xiaozhi Zhao More articles by this author Wenmin Cao More articles by this author Wenli Diao More articles by this author Hongqian Guo More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...